Published in Asian J Transfus Sci on July 01, 2012
Study of adverse whole blood donor reactions in normal healthy blood donors: experience of tertiary health care centre in jammu region. Indian J Hematol Blood Transfus (2014) 0.78
The need to label red blood cell units with their haemoglobin content: a single centre study on haemoglobin variations due to donor-related factors. Blood Transfus (2014) 0.76
A Randomized Control Study to Evaluate Effects of Short-term Oral Iron Supplementation in Regular Voluntary Blood Donors. Indian J Hematol Blood Transfus (2015) 0.75
A study of the noncompliance of blood banks on safety and quality parameters in blood donation camps in Bengaluru. Asian J Transfus Sci (2015) 0.75
Adverse Reactions in Allogeneic Blood Donors: A Tertiary Care Experience from a Developing Country. Oman Med J (2016) 0.75
Complications related to blood donation: A multicenter study of the prevalence and influencing factors in voluntary blood donation camps in Karnataka, India. Asian J Transfus Sci (2016) 0.75
The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia. Saudi Med J (2016) 0.75
A Study on the Effect of Pre-donation Salt Loading on Vasovagal Reactions in Young College Going Whole Blood Donors. Indian J Hematol Blood Transfus (2017) 0.75
Incidence, predictors and severity of adverse events among whole blood donors. PLoS One (2017) 0.75
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA (2008) 2.65
Donor reactions and injuries from whole blood donation. Transfus Med Rev (1997) 2.17
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion (2008) 1.77
Donor reactions in high-school donors: the effects of sex, weight, and collection volume. Transfusion (2006) 1.70
Donation reactions among autologous donors. Transfusion (1990) 1.67
Vasovagal reaction rates and body weight: findings in high- and low-risk populations. Transfusion (2003) 1.63
A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion (1999) 1.48
A study of criteria for blood donor deferral. Transfusion (1980) 1.39
Convulsive syncope in blood donors. Ann Neurol (1982) 1.35
Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transfus Apher Sci (2005) 1.26
Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India (2004) 1.23
Moderate and severe reactions in blood donors. Transfusion (1992) 1.01
Vasovagal reactions in 'at risk' donors: a univariate analysis of effect of age and weight on the grade of donor reactions. Transfus Apher Sci (2008) 0.99
Donor reactions among African-American and Caucasian first-time whole-blood donors. Transfusion (2005) 0.84
Prediction of fainting in blood donors. Circulation (1961) 0.84
Baroreflex sensitivity during noxious stimulation in vasovagal reactors to blood donation. Int J Psychophysiol (1995) 0.83
National blood programs in developed countries. Transfusion (1996) 0.81
Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med (2013) 3.57
Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci (2010) 2.44
Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res (2006) 2.02
Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort. Asian J Transfus Sci (2011) 1.94
Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology (2008) 1.65
Feasibility of pre-operative autologous blood donation in Indian patients with elective orthopaedic surgery. Indian J Med Res (2006) 1.41
Hemovigilance program-India. Asian J Transfus Sci (2013) 1.33
Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India (2004) 1.23
Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci (2009) 1.23
Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol (2008) 1.19
Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty (2011) 1.14
Platelet alloimmunization in multitransfused patients with haemato-oncological disorders. Natl Med J India (2005) 1.09
Bone marrow trephine biopsy as an adjunct to bone marrow aspiration. J Assoc Physicians India (2002) 1.06
Platelet-rich plasma for knee osteoarthritis. Am J Sports Med (2013) 1.06
Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study. Cell Transplant (2014) 1.04
Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study. Int Orthop (2013) 1.03
Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res (2006) 0.99
Leukoreduced blood components: Advantages and strategies for its implementation in developing countries. Asian J Transfus Sci (2010) 0.94
Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy. Transfus Apher Sci (2010) 0.94
First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers. Hematology (2007) 0.90
Transfusion related acute lung injury. Indian J Pathol Microbiol (2009) 0.88
Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia. Ther Apher Dial (2004) 0.87
Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India. Transfus Apher Sci (2013) 0.87
Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study. Neurol India (2012) 0.86
Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr (2002) 0.86
Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay. Asian J Transfus Sci (2013) 0.85
White particulate matter in a packed red blood cells unit. Asian J Transfus Sci (2011) 0.85
Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study. Nephrology (Carlton) (2015) 0.84
Congenital dyserythropoietic anemia: clinical and hematological profile. Indian Pediatr (2003) 0.84
Significance of serological monitoring in a Bombay Rh (D) negative phenotype pregnant woman: a case report. Transfus Apher Sci (2012) 0.83
Acute hemolytic transfusion reaction by anti-P1 antibody in pregnancy. Am J Hematol (2005) 0.83
Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India. Transfus Apher Sci (2011) 0.81
Successful management of pregnancy-associated severe aplastic anemia. Eur J Obstet Gynecol Reprod Biol (2006) 0.80
Serial assessment of biochemical parameters of red cell preparations to evaluate safety for neonatal transfusions. Indian J Med Res (2010) 0.80
Severe ABO hemolytic disease of newborn with a positive direct antiglobulin test. Indian J Pathol Microbiol (2009) 0.80
Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy. J Orthop Surg (Hong Kong) (2015) 0.80
Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients. Indian J Hematol Blood Transfus (2008) 0.76
Thrombocytosis as a predictor of serious bacterial infection. Indian Pediatr (2010) 0.76
Biodistribution of 18F-FDG-Labeled Autologous Bone Marrow-Derived Stem Cells in Patients With Type 2 Diabetes Mellitus: Exploring Targeted and Intravenous Routes of Delivery. Clin Nucl Med (2015) 0.76
Safety profile of bone marrow mononuclear stem cells in the rehabilitation of patients with posttraumatic facial nerve paralysis-a novel modality (phase one trial). J Neurol Surg B Skull Base (2012) 0.76
Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Am J Hematol (2005) 0.76
Hemolytic disease of fetus and newborn due to anti-E alloantibody in a newborn of Rh (D)-positive mother. Asian J Transfus Sci (2012) 0.75
Allergic contact dermatitis to antiseptic medicated dressing applied on phlebotomy site. Asian J Transfus Sci (2010) 0.75
Visual inspection of platelet concentrates; still an essential prerelease check. Asian J Transfus Sci (2012) 0.75
Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy. BMC Nephrol (2013) 0.75
Pre-apheresis donor platelet count: an important platelet yield predictor. J Clin Apher (2006) 0.75
Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis (2012) 0.75
Platelet-rich plasma for knee osteoarthritis--authors' response. Am J Sports Med (2013) 0.75
Bone marrow cryptococcosis in a human immunodeficiency virus-negative patient. Br J Haematol (2003) 0.75
Prognostic significance of the histomorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia. Anal Quant Cytol Histol (2007) 0.75
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia. J Pediatr Hematol Oncol (2011) 0.75
Acute haemolytic transfusion reaction by Le(a) alloantibody. Am J Hematol (2006) 0.75
Post renal transplant immune-mediated hemolysis: role of passenger lymphocytes. Am J Hematol (2005) 0.75
Anti Kell allo-antibody in a thalassaemic. Indian J Pathol Microbiol (2006) 0.75
Combination of rituximab with therapeutic plasma exchange in a refractory case of thrombotic thrombocytopenic purpura (TTP). Transfus Apher Sci (2013) 0.75
Alloimmunization to both Rh and Kell system antigens (anti-C and anti-K) in a young thalassemic patient. Indian J Pathol Microbiol (2010) 0.75
Pathology teach and tell: congenital myelodysplastic syndrome with extensive hepatic fibrosis. Pediatr Pathol Mol Med (2003) 0.75
Alternative to providing ABO-incompatible donors for patients in end-stage renal disease: renal transplant registries, the need of the hour. Immunohematology (2015) 0.75
Application of an artificial neural network in the prognosis of chronic myeloid leukemia. Anal Quant Cytol Histol (2011) 0.75
Transfusion medicine illustrated. Bacterial contamination of platelets: abnormal appearance prevents catastrophic events. Transfusion (2007) 0.75
Comparison of gel test and conventional tube test for antibody detection and titration in D-negative pregnant women: study from a tertiary-care hospital in North India. Immunohematology (2010) 0.75
Acute lymphoblastic leukemia presenting as cyclic neutropenia. Pediatr Hematol Oncol (2002) 0.75